Drug Shortage Report for TEVA-RIZATRIPTAN ODT

Last updated on 2022-09-23 History
Report ID 169983
Drug Identification Number 02396661
Brand name TEVA-RIZATRIPTAN ODT
Common or Proper name TEVA-RIZATRIPTAN OD
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-09-22
Estimated end date 2022-11-10
Actual end date
Shortage status Actual shortage
Updated date 2022-09-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-09-23 English Compare
v2 2022-09-22 French Compare
v1 2022-09-22 English Compare

Showing 1 to 3 of 3